Introduction
Varicose veins are enlarged lumpy visible veins caused by reflux of blood in the superficial veins of the leg 1 . They are extremely common, affecting more than half of the population in Western Europe and North America 2 -4 . Varicose veins can cause symptoms such as pain, aching, swelling, throbbing, cramping, itching and bleeding 5 . Complications include superficial thrombophlebitis, external bleeding, lipodermatosclerosis, eczema and ulceration 6, 7 . Traditionally, treatment comprised surgery with stripping of the great saphenous vein and removal of the varicose veins through small incisions (avulsions or phlebectomies). However, in the past decade new less invasive treatments have been developed 8 . In 2009-2010, 35 659 varicose vein procedures were carried out in the National Health Service (NHS) 8 .
Patient-reported outcome measures (PROMs) provide a means by which the impact of varicose veins or their treatments on quality of life can be measured. The questionnaires are typically developed from qualitative studies involving patients and clinicians. The items in these questionnaires are then tested for their ability to capture the patient's experience in prospective surveys, using psychometric analyses to explore the relationship of the items with each other and their overall ability to detect change 9 . The NHS PROMs programme has been collecting PROMs data from patients undergoing varicose vein interventions since April 2009 using generic and disease-specific PROMs 10 .
The aim of this study was to identify and examine the quality of the psychometric evidence for PROMs used in patients with varicose veins. This study was divided into two parts; initially a systematic review was undertaken to identify the appropriate papers, and then a psychometric assessment was undertaken to assess the quality of the methods used to validate or design these PROMs.
Methods
A systematic review was undertaken and reported in accordance with the general principles recommended in the PRISMA statement 11 . The protocol for the systematic review was developed and registered in the PROSPERO international prospective register of systematic reviews before the start of the data extraction 12 .
Systematic searches were undertaken in MEDLINE and MEDLINE In-Process, Embase, the Cochrane Library, CINAHL, PROQOLID, PsycINFO and Web of Science. A two-stage search approach was used. The first stage used general terms for PROMs (known generic and condition-specific PROMs) and terms for the condition (varicose veins) to identify studies. These were retrieved, and the title and abstract examined for additional PROM terms used in patients with varicose veins. The second stage incorporated these terms with the preliminary search strategy and a methodological search filter for finding studies on measurement properties. Databases were searched from inception up to July 2016 for search 1 and for search 2. Searches were supplemented by hand-searching reference lists of relevant reviews and included studies, citation search of included studies and contact with experts in the field. Search strategies are shown in Appendix S1 (supporting information).
Study selection
The titles were reviewed, and the abstracts and full text of the included articles were assessed by at least two reviewers independently. Any disagreements in the selection process were resolved by discussion, with involvement of a third reviewer. Eligible studies included articles published in English of any study design that reported the validation or development of PROMs capturing quality of life, health status or functional limitation in patients with varicose veins in an English-speaking population ( Table 1) .
Data abstraction
Data relating to study design, patient characteristics, type of treatment, PROM used, methods and outcomes were extracted by one reviewer on to a standardized data extraction form, and independently checked for accuracy by a second. Any discrepancies were resolved by discussion, with involvement of a third reviewer. Where necessary, study authors were contacted for missing information or additional data.
Methodological quality assessment (psychometric evaluation)
The methodological quality assessment in developing the PROMs was based on specific psychometric criteria. Owing to lack of consensus on how to appraise PROMs, the study-specific criteria were adapted from published recommendations 13 19 . These criteria can be divided into four areas: reliability, validity, responsiveness and acceptability ( Table 2) . Two independent researchers appraised these psychometric properties for each PROM independently using the following methods of assessment. A rating scale was designed to allocate a mark for each domain: 0, not reported; -, evidence not in favour; +/-, conflicting evidence; and +, evidence in favour. Any disagreements were resolved through discussion or with involvement of a psychometrics expert.
Assessment of reliability
The reliability of a PROM is its ability to produce the same results when measurements are repeated in populations with similar characteristics 20 . The reliability of each identified PROM was assessed by examining the reported data on reproducibility and internal consistency. The reproducibility of an instrument is commonly examined by performing test-retest at different time points. The degree of correlation is examined between the scores at baseline and those at different time points. PROMs should report test-retest using the intraclass correlation or weighted κ score; this should be at least 0⋅70 for group comparisons 20 .
PROMs commonly use more than one item to measure a single dimension that is important to the patient; this is because several related observations can produce a better estimate than one. These items need to be homogeneous; this means that they all measure aspects of a single attribute rather than different ones and are therefore internally PROM, patient-reported outcome measure; EQ, EuroQol; SF, Short Form. Table 2 Psychometric criteria used to assess the quality of the patient-reported outcome measures included in this study
Domain Criteria
Test-retest reliability Test-retest: the intraclass correlation/weighted κ score should be ≥ 0⋅70 for group comparisons and ≥ 0⋅90 if scores are going to be used for decisions about an individual based on their score 19 The mean difference (paired t test or Wilcoxon signed-rank test) between time points 1 and 2, and the 95% c.i.
should also be reported 12, 13 Internal consistency A Cronbach's α score of ≥ 0⋅70 is considered good, and it should not exceed ≥ 0⋅92 for group comparisons as this is taken to indicate that items in the scale could be redundant. Item total correlations should be ≥ 0⋅20 14, 20 
Content validity
This is assessed qualitatively during the development of an instrument. To achieve good content validity, there must be evidence that the instrument has been developed by consulting patients and experts as well as undertaking a literature review 20 Patients should be involved in the development stage and item generation. The opinion of patient representatives should be sought on the constructed scale 12 -14 Construct validity A correlation coefficient of ≥ 0⋅60 is taken as strong evidence of construct validity. Authors should make specific directional hypotheses and estimate the strength of correlation before testing 12 -14 Criterion validity A good argument should be made as to why an instrument is standard and correlation with the standard should be ≥ 0⋅70 15 19 Responsiveness There are a number of methods to measure responsiveness, including t tests, effect size, standardized response means or Guyatt's responsiveness index. There should be statistically significant changes in score of an expected magnitude 21, 22 Floor and ceiling effects A floor or ceiling effect is considered if 15% of respondents are achieving the lowest or the highest score on the instrument 12,13 Acceptability Acceptability is measured by the completeness of the data supplied; ≥ 80% of the data should be complete 12 consistent 13 . Internal consistency is usually measured using Cronbach's α, which should have a value of more than 0⋅70 and less than 0⋅90 for the proposed PROM to be psychometrically sound 13, 23 .
Assessment of validity
Validity is the measure of how well a PROM measures what it is intended to measure. Validity was assessed for each identified PROM by assessing content validity, construct validity and criterion validity. Content validity was measured by examining the relevance of the items in the PROM to their intended use. This was assessed on the basis of whether these items were developed through qualitative studies with patient groups involving clinicians and incorporating published evidence 23 . Criterion validity is concerned with assessing the PROM in question against a standard PROM that provides a benchmark of the true values.
The new PROM should demonstrate correlation coefficient scores of more than 0⋅70. However, in reality this is often very difficult to assess in the absence of such a standard 14, 15 .
Records identified through database searching n = 3787
Additional records identified through updated search and other sources n = 83
Records after duplicates removed n = 3036
Abstracts reviewed n = 81
Records excluded based on reviewing abstracts n = 44 Only reporting results of PROMs; no attempt to develop or validate PROMs n = 44
Full-text articles with psychometric data assessed for eligibility n = 37
Full-text articles excluded n = of a measure can be calculated using methods such as standardized response means, t test, effect size and Guyatt's responsiveness ratio 21, 22, 24 .
Assessment of acceptability and floor or ceiling effect
Acceptability is measured by the completeness of the data. For a PROM to show a good level of acceptability, 80 per cent or more of the data should be complete when the PROM is administered to patients 19 . A floor or ceiling effect is considered if 15 per cent of respondents are achieving the lowest or the highest score on the instrument.
Results
A total of 3787 records were identified; following detailed examination, nine studies 25 -33 (reporting on 4 PROMs) were included (Fig. 1) . PROMs that were not specific for varicose veins and examined chronic venous disease in general were excluded; examples of these are the ChronIc Venous Insufficiency quality of life Questionnaire (CIVIQ)-20 and CIVIQ-14, both chronic venous disease PROMs, and the Venous Insufficiency Epidemiologic and Economic Study -Quality of Life/Symptoms (VEINES-QOL/Sym), a PROM validated in patients with deep venous thrombosis and venous leg ulcers. All the included studies assessed the psychometric properties and suitability of the suggested PROMs in patients with varicose veins ( Table 3 ). The studies were prospective in design, and were undertaken in the UK and USA. They were published between 1993 and 2016. The majority of the studies were of a small to moderate size with the number of patients ranging from 40 33 to 1700 26, 27 . Patients aged between 16 and 86 years were recruited in the included studies, with the proportion of men ranging from 24 per cent 25 to 48 per cent 29 . 32 . The protocol regarding timing of PROMs differed between the studies. The shortest follow-up was immediately following the intervention and the longest was 12 months after treatment. The rigour of the psychometric assessment of the PROMs was variable. The AVVQ was the only instrument evaluated in detail, with assessment of all the important psychometric domains ( Table 4) .
Short Form 36-Health Survey
Garratt and colleagues 25 -28 assessed aspects of the psychometric validity of this generic instrument in patients with varicose veins. In a study of 1700 patients, including 314 with varicose veins, the SF-36 ® was examined for its suitability as a PROM for patients treated in the NHS. The internal consistency was assessed using two techniques, item scale correlation and Cronbach's α. The first method examined the extent to which an item was related to the rest of the scale, whereas Cronbach's α measured the overall correlation between items in the scale. The correlation for all items was above 0⋅4, providing evidence of internal consistency. The Cronbach's α value exceeded 0⋅8 and satisfied the criteria for internal consistency. The response rate for the SF-36 ® in this study at baseline was 75⋅5 per cent, showing some evidence of acceptability for this PROM; however, this dropped to 67⋅5 per cent after 1 year. The construct validity assessment used ordinary least regression to estimate the effect on each scale in the PROM of varicose veins, age, sex and socioeconomic status of the participants. The impact of varicose veins was significant only on the physical functioning scale. The responsiveness of SF-36 ® was assessed in the same population after 12 months, with results showing good responsiveness for this PROM. The standardized response mean was used to measure this property, and patients with varicose veins had a significantly higher level of improvement across the SF-36 ® scales at 1 year than those not referred for treatment.
Aberdeen Varicose Vein Questionnaire
This disease-specific PROM was developed by Garratt et al. 25 , and the items were generated based on questions commonly used to assess patients with varicose veins. The items generated were confirmed by two clinicians and then pretested in patients for relevance and validity 25 . The AVVQ was tested for internal consistency, construct and criterion validity, and acceptability. The result of internal consistency evaluation after removing five questions that did not fulfil the criteria was a Cronbach's α value of 0⋅72, satisfying the psychometric criterion for this PROM 34 . The construct validity of the instrument was tested using stepwise multiple regression and comparison with the Varicose Vein Severity Score. The regression model confirmed that AVVQ explains a substantial proportion of the non-random variation in the patients' perceived health. The AVVQ showed high acceptability 28 0 among patients with 76 per cent complete data when the PROM was administered 25 . The criterion validity of the AVVQ was assessed by comparing it with eight scales of the SF-36 ® in patients with varicose veins; the AVVQ achieved highly negative correlations with all eight scales of the SF-36 ® 28 . Four of these correlations exceeded 0⋅4, including physical functioning, pain, social functioning and role limitations. These correlations suggest that AVVQ can pick up adverse effects of varicose veins better than the generic PROM SF-36 ® . The test-retest reliability assessment of this PROM showed an intraclass correlation coefficient of above 0⋅7 in all domains except one, in which patients reported no change in symptoms after 1 year. The responsiveness of the AVVQ to changes in health over time was assessed by administering the questionnaire to the same respondents after 1 year 28 . In an analysis of standardized response means over 1 year, all items showed improvement, especially for patients who received treatment; patients not referred to a specialist had lower perceived health compared with the general population 28 .
Lattimer and colleagues 30 attempted to examine the responsiveness of the AVVQ in patients receiving endogenous laser ablation or foam sclerotherapy for varicose veins as part of an RCT. The patients included in the study all had primary disease with no previous intervention. The Wilcoxon signed-rank test was used to compare differences within the same group before and after intervention. Spearman's ρ was used to assess the correlation between the severity of symptoms and AVVQ outcomes. The study reported improved AVVQ score after 3 weeks and 3 months of follow-up 29, 30 .
Varicose Veins Symptoms Questionnaire
This electronic PROM was developed in accordance with FDA guidance 18 . This included qualitative studies that involved patients to generate the five items in the PROM, all related to symptoms alone. The psychometric properties were examined as part of two RCTs (VANISH-1 and VANISH-2) evaluating microfoam ablation with varying doses of polidocanol endovenous microfoam in patients with varicose veins 31, 33 . Test-retest reliability was examined using intraclass correlation coefficients to assess whether VVSymQ ® yielded a reproducible score in patients exhibiting no change in health status. The reported intraclass correlation coefficient was 0⋅75, demonstrating acceptable test-retest reliability. Cronbach's α value was 0⋅76 showing good internal consistency of the items included in the PROM. The construct validity was evaluated through Pearson correlation analyses; the score from the PROM showed correlations with reported clinical outcomes 31 . The VVSymQ ® score captured meaningful clinical change and treatment impact, with an effect size of 1⋅6 when the scores were compared between baseline and 6 weeks after intervention. This electronic PROM had between 86⋅1 and 97 per cent data completion, reflecting good acceptability among the patients 31, 33 .
Specific Quality-of-life and Outcome Response -Venous
This instrument consists of 46 items divided into five domains: physical discomfort, appearance, restriction in movement, emotional problems and threat to health. All patients in the study 32 underwent radiofrequency ablation. The performance of the PROM was tested against the AVVQ and other clinical outcomes. The scores from the AVVQ and SQOR-V showed strong positive correlation with a Spearman coefficient of 0⋅702 (P < 0⋅001).
Responsiveness was tested at 6 weeks, with poor results for SQOR-V in some patient groups compared with the AVVQ. The acceptability, as measured by the completeness of the data, was weak (67 per cent complete data) 32 .
Discussion
This study identified PROMs that have undergone validation in patients with varicose veins, and assessed the methodology of psychometric validation in accordance with FDA guidance, Oxford University PROMs Group guidelines and COSMIN 13 -19 . Patient-reported outcome is an important core outcome recommended to be collected as part of service analysis and clinical studies 35 -37 . Clinicians and researchers are faced with a dilemma when deciding on the instrument that measures this outcome. In the UK NHS, the measures used to collect data on PROMs for patients undergoing surgical management for varicose veins are the AVVQ and EuroQoL Five Dimensions (EQ-5D™; EuroQol Group, Rotterdam, The Netherlands 38 .
This review identified only one generic measure (SF-36 ® ) and three disease-specific instruments (AVVQ, VVSymQ ® , SQOPR-V) that have undergone psychometric assessment in patients with varicose veins. The evidence suggests that the SF-36 ® exhibits good internal consistency and acceptability among patients with varicose veins, with some evidence of construct validity and responsiveness. The AVVQ had good test-retest reliability, construct and criterion validity, and responsiveness. However, the evidence for the content validity was weak, and clinicians and researchers generated the items with limited input from patients; the weighting of the items was based on the judgement of two clinicians. VVSymQ ® had good internal consistency, test-retest reliability, construct, content and criterion validity, and responsiveness. The acceptability of the VVSymQ ® was better than that of the AVVQ and SF-36 ® ; this is in part because it is an electronic questionnaire; however, the only domain in this instrument is symptoms.
The main strength of this study was the use of comprehensive search strategies to identify all relevant papers that reported on psychometric validation of PROMs for patients with varicose veins. The psychometric assessment domains in this study were based on different but overlapping psychometric evaluation criteria 16, 18, 19, 38 . The main limitation of the analysis was the heterogeneity of the patients included in the studies as well as the different protocols for administering the PROMs. Furthermore, the content validity of the disease-specific measures was based on information limited to either that gathered by consulting a small number of patients about items generated by researchers and clinicians, or data from small qualitative research studies, with no systematic review of the qualitative evidence 25,27 -31,33 . None of the studies included in the review provided any information on how they dealt with missing data.
The only generic PROM with psychometric evidence to support its use in patients with varicose veins was the SF-36 ® ; no data on the EQ-5D™ were found. The AVVQ was the most evaluated disease-specific PROM, with five studies examining its psychometric validity. Further work is needed to improve the content validity and acceptability of PROMs used in patients with varicose veins. The authors also recommend further research on the use of electronic PROMs based on the acceptability data for the VVSymQ ® .
